Myelofibrosis Clinical Trials

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

Mayo Clinic
Scottsdale Arizona 85259

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

CTI Investigational Site 10002
Scottsdale Arizona 85259
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

University of California San Diego
San Diego California

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

Stanford University Medical center
Stanford California 94305

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Washington District of Columbia 20007

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Jacksonville Florida 32224

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

Winter Park Florida 32789

Patients are needed to participate in a clinical research study evaluating Ruxolitinib for the treatment of Myelofibrosis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Honolulu Hawaii 96813

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

Baltimore Maryland 21229

Patients are needed to participate in a clinical research study evaluating Ruxolitinib for the treatment of Myelofibrosis

Mayo Clinic
Rochester Minnesota 55905

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Washington University in St. Louis
St. Louis Missouri 63110

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

CTI Investigational Site 10001
Morristown New Jersey 07962
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Icahn School of Medicine at Mount Sinai
New York New York 10029

A Phase 2 clinical study for patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis or Post Essential Thrombocythemia Myelofibrosis

Oncology Hematology Care Clinical Trials
Cincinnati Ohio

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

Cleveland Clinic
Cleveland Ohio

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

Luitpold Pharmaceuticals, Inc.
Norristown Pennsylvania 19403

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Charleston South Carolina 29425

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

CTI Investigational Site 10003
Greenville South Carolina 29601
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Tennessee Oncology
Nashville Tennessee

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

MD Anderson Cancer Center
Houston Texas 77030

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

The University of Texas MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Ruxolitinib for the treatment of Myelofibrosis

MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study of TXA127 300 mcg/kg/day and TXA127 1000 mcg/kg/day

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Salt Lake City Utah 84132

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

Fred Hutchinson Cancer Research Center
Seattle Washington 98109

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating LY2784544 for the treatment of Myeloproliferative Neoplasms of, Polycythemia Vera, Essential Thrombocythemia or Myelofibrosis

Novartis Investigative Site
Buenos aires Entre Rios E3100BBJ

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Buenos Aires C1114AAN

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Buenos Aires C1221ADC

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Caba Buenos Aires 1209

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Cordoba X5016KEH

A clinical trial seeking patients for a research study of INC424

CTI Investigational Site 61006
Box Hill
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

CTI Investigational Site 61001
Coffs Harbour
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

CTI Investigational Site 61005
Geelong
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

CTI Investigational Site 61004
Hobart
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

CTI Investigational Site 61002
Milton
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Novartis Investigative Site
Graz A-8036

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Linz A-4010

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Linz 4010

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Salzburg 5020

A clinical trial seeking patients for a research study of INC424

Novartis Investigative Site
Wien A-1090

A clinical trial seeking patients for a research study of INC424

CTI Investigational Site 32002
Antwerp
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

CTI Investigational Site 32003
Antwerp
Updated

A Phase 3 clinical study for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Novartis Investigative Site
Brugge 8000

A clinical trial seeking patients for a research study of INC424